| Reaction Details |
|---|
 | Report a problem with these data |
| Target | P2X purinoceptor 1 |
|---|
| Ligand | BDBM50563052 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | ChEMBL_2147580 (CHEMBL5031926) |
|---|
| IC50 | >30000±n/a nM |
|---|
| Citation |  Kai, H; Horiguchi, T; Kameyma, T; Onodera, N; Itoh, N; Fujii, Y; Ichihashi, Y; Hirai, K; Shintani, T; Nakamura, K; Minami, K; Kasai, E; Yoneda, S; Murakami, Y; Ogawa, H; Sekimoto, R; Shinohara, S; Yoshida, O; Kurose, N Discovery of clinical candidate Sivopixant (S-600918): Lead optimization of dioxotriazine derivatives as selective P2X3 receptor antagonists. Bioorg Med Chem Lett52:0 (2021) [PubMed] Article |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| P2X purinoceptor 1 |
|---|
| Name: | P2X purinoceptor 1 |
|---|
| Synonyms: | ATP receptor | P2RX1 | P2RX1_HUMAN | P2X1 | Purinergic receptor | Purinergic, P2X |
|---|
| Type: | Enzyme Catalytic Domain |
|---|
| Mol. Mass.: | 44992.65 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | Purinergic, P2X 0 HUMAN::P51575 |
|---|
| Residue: | 399 |
|---|
| Sequence: | MARRFQEELAAFLFEYDTPRMVLVRNKKVGVIFRLIQLVVLVYVIGWVFLYEKGYQTSSG
LISSVSVKLKGLAVTQLPGLGPQVWDVADYVFPAQGDNSFVVMTNFIVTPKQTQGYCAEH
PEGGICKEDSGCTPGKAKRKAQGIRTGKCVAFNDTVKTCEIFGWCPVEVDDDIPRPALLR
EAENFTLFIKNSISFPRFKVNRRNLVEEVNAAHMKTCLFHKTLHPLCPVFQLGYVVQESG
QNFSTLAEKGGVVGITIDWHCDLDWHVRHCRPIYEFHGLYEEKNLSPGFNFRFARHFVEN
GTNYRHLFKVFGIRFDILVDGKAGKFDIIPTMTTIGSGIGIFGVATVLCDLLLLHILPKR
HYYKQKKFKYAEDMGPGAAERDLAATSSTLGLQENMRTS
|
|
|
|---|
| BDBM50563052 |
|---|
| n/a |
|---|
| Name | BDBM50563052 |
|---|
| Synonyms: | CHEMBL4748113 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C23H25ClN4O5 |
|---|
| Mol. Mass. | 472.921 |
|---|
| SMILES | CC(C)Oc1ccc(Nc2nc(=O)n(CCC(O)=O)c(=O)n2Cc2ccc(C)cc2)cc1Cl |
|---|
| Structure | 
|
|---|
Search and Browse
